Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by blackspade799on Sep 16, 2023 7:52pm
184 Views
Post# 35640014

House to vote on CURE Act

House to vote on CURE Act

A congressional committee next week will vote on a bill to protect people from being denied federal employment or security clearances due to marijuana use—and to provide relief for people who lost opportunities due to cannabis in the past.

The House Oversight and Accountability Committee will hold a markup on the legislation, the Cannabis Users’ Restoration of Eligibility (CURE) Act, on Wednesday, Chairman James Comer (R-KY) announced late Friday.

 House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) announced a markup for Wednesday, September 20 at 10:00am ET

  • H.R. 5040, the Cannabis Users Restoration of Eligibility (CURE) Act: The bill prevents prior marijuana use from becoming grounds for failing to receive security clearance or for being found unsuitable for federal employment. The CURE Act will also allow for someone who has previously been denied a security clearance or a federal job opportunity based on marijuana use the chance to have that denial reviewed.


https://oversight.house.gov/release/comer-announces-full-committee-markup/

https://www.marijuanamoment.net/congressional-committee-will-vote-on-removing-marijuana-as-barrier-to-federal-employment-or-security-clearances/

<< Previous
Bullboard Posts
Next >>